Thanks for the link. This as you know doesn't inv

Thanks for the link.
This as you know doesn't involve leronlimab but rather straight allogenic immunity. To me it just shows that our guys in the article are good doctor/researchers after a cure for HIV, going wherever their work leads them.
But since we can't practically speaking do marrow transplants on the millions of HIV patients in the world, that leaves long-acting leronlimab and AAV-delivered leronlimab still very much in the running.